Immunoprecise Historical Financial Ratios

IPA
 Stock
  

USD 3.80  0.04  1.04%   

Immunoprecise Antibodies is lately reporting on over 66 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Current Ratio of 9.98 or Debt to Equity Ratio of 0.16 will help investors to properly organize and evaluate Immunoprecise Antibodies financial condition quickly. Financial Statement Analysis is infinitely more than just reviewing and investigating Immunoprecise Antibodies recent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immunoprecise Antibodies is a good buy for the upcoming year.
Please see Risk vs Return Analysis.
  
Refresh

About Immunoprecise Financial Ratios Analysis

Immunoprecise AntibodiesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Immunoprecise Antibodies investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Immunoprecise financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Immunoprecise Antibodies history.

Immunoprecise Antibodies Financial Ratios Chart

Immunoprecise Antibodies financial ratios usually calculated using numerical values taken directly from Immunoprecise Antibodies financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Immunoprecise Antibodies. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
Immunoprecise Antibodies Current Ratio is projected to increase based on the last few years of reporting. The past year's Current Ratio was at 9.25. The current year Tangible Assets Book Value per Share is expected to grow to 4.00, whereas Book Value per Share is forecasted to decline to 3.25.

Asset Turnover

Asset turnover is a measure of a firms operating efficiency; calculated by dividing Revenues by Average Assets. Often a component of DuPont ROE analysis.

Return on Average Assets

Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].

Return on Average Equity

Return on equity measures a corporation's profitability by calculating the amount of Net Income Common Stock returned as a percentage of [EquityAvg].

Return on Sales

Return on Sales is a ratio to evaluate a company's operational efficiency; calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont ROE analysis.
Most ratios from Immunoprecise Antibodies fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Immunoprecise Antibodies current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.Immunoprecise Antibodies Current Ratio is projected to increase based on the last few years of reporting. The past year's Current Ratio was at 9.25. The current year Tangible Assets Book Value per Share is expected to grow to 4.00, whereas Book Value per Share is forecasted to decline to 3.25.
 2020 2021 2022 (projected)
Book Value per Share3.463.973.25
Asset Turnover0.380.340.36

Immunoprecise Antibodies fundamentals Correlations

-0.99-0.990.94-0.75-0.36-0.36-0.76-0.76-0.82-0.96-0.650.84-0.760.840.02-0.9-0.98-0.8-0.98
-0.990.98-0.960.680.30.30.760.760.760.920.59-0.790.76-0.780.080.930.980.740.95
-0.990.98-0.950.740.340.340.70.70.810.960.64-0.840.7-0.84-0.050.890.980.780.97
0.94-0.96-0.95-0.51-0.09-0.09-0.64-0.64-0.61-0.82-0.40.75-0.640.75-0.04-0.88-0.94-0.58-0.86
-0.750.680.74-0.510.870.870.50.50.990.870.98-0.570.5-0.570.070.720.760.990.84
-0.360.30.34-0.090.871.00.160.160.830.530.94-0.130.16-0.120.320.470.410.850.47
-0.360.30.34-0.090.871.00.160.160.830.530.94-0.130.16-0.120.320.470.410.850.47
-0.760.760.7-0.640.50.160.161.00.530.770.4-0.851.0-0.84-0.260.520.640.510.78
-0.760.760.7-0.640.50.160.161.00.530.770.4-0.851.0-0.84-0.260.520.640.510.78
-0.820.760.81-0.610.990.830.830.530.530.910.97-0.60.53-0.60.120.80.831.00.88
-0.960.920.96-0.820.870.530.530.770.770.910.78-0.870.77-0.87-0.120.820.930.891.0
-0.650.590.64-0.40.980.940.940.40.40.970.78-0.430.4-0.430.20.680.680.980.74
0.84-0.79-0.840.75-0.57-0.13-0.13-0.85-0.85-0.6-0.87-0.43-0.851.00.54-0.52-0.73-0.57-0.87
-0.760.760.7-0.640.50.160.161.01.00.530.770.4-0.85-0.84-0.260.520.640.510.78
0.84-0.78-0.840.75-0.57-0.12-0.12-0.84-0.84-0.6-0.87-0.431.0-0.840.54-0.52-0.73-0.57-0.87
0.020.08-0.05-0.040.070.320.32-0.26-0.260.12-0.120.20.54-0.260.540.40.130.15-0.1
-0.90.930.89-0.880.720.470.470.520.520.80.820.68-0.520.52-0.520.40.960.790.85
-0.980.980.98-0.940.760.410.410.640.640.830.930.68-0.730.64-0.730.130.960.820.95
-0.80.740.78-0.580.990.850.850.510.511.00.890.98-0.570.51-0.570.150.790.820.86
-0.980.950.97-0.860.840.470.470.780.780.881.00.74-0.870.78-0.87-0.10.850.950.86
Click cells to compare fundamentals

Immunoprecise Antibodies Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Focused Opportunities Now

   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
90.4 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.